Institute of Biomedical & Clinical Science: Recent submissions
Now showing items 11-15 of 1236
-
Diabetes, cardiovascular disease and the microcirculation
(BMC, 18 April 2018)Cardiovascular disease (CVD) is the leading cause of mortality in people with type 2 diabetes mellitus (T2DM), yet a significant proportion of the disease burden cannot be accounted for by conventional cardiovascular risk ... -
Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 Diabetes
(Springer, 8 April 2021)Prognosis and appropriate treatment goals for older adults with diabetes vary greatly according to frailty. It is now recognised that changes may be needed to diabetes management in some older people. Whilst there is clear ... -
Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice
(Springer, 19 January 2022)While glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide, are among the most effective drugs for treating people with type 2 diabetes (T2D), they are clinically under-utilised. Until recently, the ... -
Defining the role of SGLT2 inhibitors in primary care: Time to think differently.
(Springer, 29 March 2022)Disease burden in people with diabetes is mainly driven by long-term complications such as cardiovascular disease, heart failure and chronic kidney disease. This is a consequence of the interconnection between the ... -
The impact of COVID vaccination on symptoms of long COVID: An international survey of people with lived experience of long COVID.
(MDPI, 21 April 2022)Long COVID is a multi-system syndrome following SARS-CoV-2 infection with persistent symptoms of at least 4 weeks, and frequently for several months. It has been suggested that there may be an autoimmune component. There ...